SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Aperion Biologics Reaches Midpoint of Enrollment in Z-Lig(TM) Anterior Cruciate Ligament Reconstruction Medical Device Performance Trial